Literature DB >> 31359006

Enhancing gene editing specificity by attenuating DNA cleavage kinetics.

Jeffrey C Miller1, Deepak P Patil1, Danny F Xia1, Charles B Paine1, Friedrich Fauser1, Hunter W Richards1, David A Shivak1, Yuri R Bendaña1, Sarah J Hinkley1, Nicholas A Scarlott1, Stephen C Lam1, Andreas Reik1, Yuanyue Zhou1, David E Paschon1, Patrick Li1, Tenzin Wangzor1, Gary Lee1, Lei Zhang1, Edward J Rebar2.   

Abstract

Engineered nucleases have gained broad appeal for their ability to mediate highly efficient genome editing. However the specificity of these reagents remains a concern, especially for therapeutic applications, given the potential mutagenic consequences of off-target cleavage. Here we have developed an approach for improving the specificity of zinc finger nucleases (ZFNs) that engineers the FokI catalytic domain with the aim of slowing cleavage, which should selectively reduce activity at low-affinity off-target sites. For three ZFN pairs, we engineered single-residue substitutions in the FokI domain that preserved full on-target activity but showed a reduction in off-target indels of up to 3,000-fold. By combining this approach with substitutions that reduced the affinity of zinc fingers, we developed ZFNs specific for the TRAC locus that mediated 98% knockout in T cells with no detectable off-target activity at an assay background of ~0.01%. We anticipate that this approach, and the FokI variants we report, will enable routine generation of nucleases for gene editing with no detectable off-target activity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31359006     DOI: 10.1038/s41587-019-0186-z

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  17 in total

1.  Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction.

Authors:  Shingo Suzuki; Ana M Crane; Varada Anirudhan; Cristina Barillà; Nadine Matthias; Scott H Randell; Andras Rab; Eric J Sorscher; Jenny L Kerschner; Shiyi Yin; Ann Harris; Matthew Mendel; Kenneth Kim; Lei Zhang; Anthony Conway; Brian R Davis
Journal:  Mol Ther       Date:  2020-04-29       Impact factor: 11.454

Review 2.  Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR.

Authors:  Yasaman Shamshirgaran; Jun Liu; Huseyin Sumer; Paul J Verma; Amir Taheri-Ghahfarokhi
Journal:  Methods Mol Biol       Date:  2022

3.  Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP.

Authors:  Benjamin C Houghton; Neelam Panchal; Simone A Haas; Kay O Chmielewski; Markus Hildenbeutel; Thomas Whittaker; Claudio Mussolino; Toni Cathomen; Adrian J Thrasher; Claire Booth
Journal:  Front Genome Ed       Date:  2022-05-23

Review 4.  Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.

Authors:  Nikolay L Malinin; GaHyun Lee; Cicera R Lazzarotto; Yichao Li; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung; Shengdar Q Tsai
Journal:  Nat Protoc       Date:  2021-11-12       Impact factor: 17.021

5.  DNA and RNA editing without sequence limitation using the flap endonuclease 1 guided by hairpin DNA probes.

Authors:  Kun Tian; Yongjian Guo; Bingjie Zou; Liang Wang; Yun Zhang; Zhen Qi; Jieying Zhou; Xiaotang Wang; Guohua Zhou; Libin Wei; Shu Xu
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 16.971

6.  ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice.

Authors:  Silvere Pagant; Marshall W Huston; Luciana Moreira; Lin Gan; Susan St Martin; Scott Sproul; Michael C Holmes; Kathleen Meyer; Thomas Wechsler; Robert J Desnick; Makiko Yasuda
Journal:  Mol Ther       Date:  2021-03-26       Impact factor: 11.454

Review 7.  Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.

Authors:  Wes Brown; Wenyuan Zhou; Alexander Deiters
Journal:  Chembiochem       Date:  2020-11-17       Impact factor: 3.164

Review 8.  Tools for experimental and computational analyses of off-target editing by programmable nucleases.

Authors:  X Robert Bao; Yidan Pan; Ciaran M Lee; Timothy H Davis; Gang Bao
Journal:  Nat Protoc       Date:  2020-12-07       Impact factor: 13.491

Review 9.  Tuning up Transcription Factors for Therapy.

Authors:  Attila Becskei
Journal:  Molecules       Date:  2020-04-20       Impact factor: 4.411

10.  Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice.

Authors:  Ana M Moreno; Fernando Alemán; Glaucilene F Catroli; Matthew Hunt; Michael Hu; Amir Dailamy; Andrew Pla; Sarah A Woller; Nathan Palmer; Udit Parekh; Daniella McDonald; Amanda J Roberts; Vanessa Goodwill; Ian Dryden; Robert F Hevner; Lauriane Delay; Gilson Gonçalves Dos Santos; Tony L Yaksh; Prashant Mali
Journal:  Sci Transl Med       Date:  2021-03-10       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.